After her hypoparathyroidism diagnosis, columnist Bari Vapnek was just going through the motions. Now, she's committed to living fully.

Encaleret increased bone turnover markers and improved patient-reported symptoms in people with autosomal dominant hypocalcemia type 1 (ADH1), a genetic form of hypoparathyroidism, in a Phase 3 trial.

Over the last 25 years, I’ve spent the majority of my days literally looking up at the sky or the ceiling. My perspective is different from most healthy people since I’ve been lying down somewhere, ...

Jennifer is an Ohio native, entrepreneur, and mother who faced a life-altering post-surgical hypoparathyroidism diagnosis in 2001, compounded by alcoholism and a multi-year mental health crisis. By ...

Guest Voice: Looking for the person I’m becoming with hypoparathyroidism Over the last 25 years, I’ve spent the majority of my days literally looking up at the sky or the ceiling. My perspective is ...

In hypoparathyroidism, the body does not produce enough parathyroid hormone (PTH), which leads to a number of different symptoms for people with the rare condition. Since PTH is involved in regulating ...

I’m often asked by fellow hypoparathyroidism patients how they can get an at-home calcium tester, and I’ve always had to explain that there wasn’t an option — until now. Finally, one is in development ...

People with hypoparathyroidism may have problems with their skin, in addition to the more serious muscular and nervous system symptoms of the disease. Here is information about how hypoparathyroidism ...

The goal of treatment for hypoparathyroidism is to ease symptoms and normalize your body’s levels of calcium and phosphorus. For optimal treatment and specialized testing, it’s recommended that you ...

What is encaleret for hypoparathyroidism? Encaleret is an orally administered small molecule being developed by Bridgebio for the treatment of autosomal dominant hypocalcemia type 1 (ADH1) — a rare ...

Entera Bio and Opko Health are teaming up to develop a once-daily oral treatment for hypoparathyroidism, known as a long-acting parathyroid hormone analog (LA-PTH). “Preclinical data of oral LA-PTH ...